Beam Therapeutics Inc.

BEAM · Healthcare · Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from seri…

Beam Therapeutics Inc. (BEAM), in the Healthcare sector, has 14 disclosed filings on Paydirt over the trailing twelve months from 7 corporate insiders: 0 purchases and 14 sales, 4 filed past the deadline. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Jul 27 and filed Jul 29. The most active filer was John M. Evans with 8 filings.

Add to watchlist

Filings, ttm

0 buys · 14 sells · 4 late

Traders, ttm

7 insiders

Volume, ttmiDollar value disclosed in the window

$19.3M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Jul 27

Filed Jul 29

ADViAverage daily dollar volume

$56.9M

market data

Share price · 12M

$28.33 (+16.1%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $27.1M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

John M. Evans CEO 8 filings GC

Giuseppe Ciaramella President 5 filings CB

Christine Bellon Chief Legal Officer 4 filings AS

Amy Simon Chief Medical Officer 3 filings BC

Bethany J Cavanagh SVP, Finance and Treasurer 2 filings FL Fmr Llc 10% owner 2 filings SE

Sravan Kumar Emany Chief Financial Officer 1 filing

Recent filings

Amy SimonSALE Chief Medical Officer $429K
16,667 sh × $25.74
Exec Jul 27
Filed Jul 29 · 4:05 PM ET John M. EvansSALE CEO $1.7M
48,100 sh across 3 lots
Exec Jun 29
Filed Jul 1 · 4:05 PM ET Fmr LlcSALE 10% owner $10.0M
284,860 sh across 2 lots
Exec Jun 25
Filed Jun 29 · 5:30 PM ET Giuseppe CiaramellaSALE President $290K
11,810 sh × $24.58
Exec Apr 1
Filed Apr 6 · 5:30 PM ET † Christine BellonSALE Chief Legal Officer $146K
5,956 sh × $24.58
Exec Apr 1
Filed Apr 6 · 5:30 PM ET † Amy SimonSALE Chief Medical Officer $165K
6,700 sh × $24.58
Exec Apr 1
Filed Apr 6 · 5:30 PM ET † John M. EvansSALE CEO $739K
30,078 sh × $24.58
Exec Apr 1
Filed Apr 6 · 5:30 PM ET † John M. EvansSALE CEO $1.1M
50,000 sh across 2 lots
Exec Mar 30
Filed Apr 1 · 5:30 PM ET Giuseppe CiaramellaSALE President $1.1M
35,000 sh × $32.00
Exec Feb 24
Filed Feb 26 · 5:30 PM ET John M. EvansSALE CEO $1.4M
47,094 sh across 3 lots
Exec Jan 29
Filed Feb 2 · 5:30 PM ET Bethany J CavanaghSALE SVP, Finance and Treasurer $217K
6,198 sh × $35.00
Exec Jan 22
Filed Jan 26 · 5:30 PM ET Christine BellonSALE Chief Legal Officer $554K
15,959 sh × $34.72
Exec Jan 15
Filed Jan 20 · 5:30 PM ET Sravan Kumar EmanySALE Chief Financial Officer $171K
6,294 sh × $27.10
Exec Dec 31 2025
Filed Jan 5 · 5:30 PM ET John M. EvansSALE CEO $1.2M
50,000 sh across 2 lots
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET Fmr LlcSALE 10% owner $992K
48,374 sh × $20.50
Exec Jul 30 2025
Filed Aug 1 2025 · 5:30 PM ET Amy SimonSALE Chief Medical Officer $548K
30,563 sh across 2 lots
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET Giuseppe CiaramellaSALE President $136K
7,434 sh × $18.35
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET John M. EvansSALE CEO $563K
30,663 sh × $18.35
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET Christine BellonSALE Chief Legal Officer $104K
5,674 sh × $18.35
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET Bethany J CavanaghSALE SVP, Finance and Treasurer $220K
6,287 sh × $35.00
Exec Feb 18 2025
Filed Feb 20 2025 · 5:30 PM ET Christine BellonSALE Chief Legal Officer $340K
10,000 sh × $34.00
Exec Feb 14 2025
Filed Feb 19 2025 · 5:30 PM ET John M. EvansSALE CEO $797K
29,800 sh × $26.75
Exec Jan 30 2025
Filed Feb 3 2025 · 5:30 PM ET Giuseppe CiaramellaSALE President $1.3M
51,110 sh × $26.36
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET Giuseppe CiaramellaSALE President $1.3M
51,110 sh × $26.27
Exec Oct 14 2024
Filed Oct 16 2024 · 5:30 PM ET John M. EvansSALE CEO $1.5M
60,000 sh × $24.60
Exec Sep 30 2024
Filed Oct 2 2024 · 5:30 PM ET